{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:58Z","timestamp":1790957998162,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.steroids.2024.109558","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T02:27:53Z","timestamp":1735525673000},"page":"109558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters"],"prefix":"10.1016","volume":"214","author":[{"given":"Shubhi","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Dadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh K.","family":"Goand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7703-9307","authenticated-orcid":false,"given":"Jiaur R.","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.steroids.2024.109558_b0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2230-8210.107858","article-title":"Clinical characteristics of polycystic ovary syndrome in Indian women","volume":"17","author":"Ramanand","year":"2013","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.steroids.2024.109558_b0015","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective","volume":"101","author":"Pasquali","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20133","key":"10.1016\/j.steroids.2024.109558_b0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"Journal of Ovarian Research"},{"issue":"8","key":"10.1016\/j.steroids.2024.109558_b0030","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2024.109558_b0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2024.109558_b0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-246X.2006.03250.x","article-title":"Pacific seamount volcanism in space and time","volume":"168","author":"Hillier","year":"2007","journal-title":"Geophys. J. Int."},{"key":"10.1016\/j.steroids.2024.109558_b0050","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.steroids.2024.109558_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14117","article-title":"Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS)","volume":"46","author":"Shahid","year":"2022","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.steroids.2024.109558_b0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygcen.2017.12.007","article-title":"Evaluation of different ranges of LH: FSH ratios in polycystic ovarian syndrome (PCOS)\u2013Clinical based case control study","volume":"260","author":"Malini","year":"2018","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109558_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174746","article-title":"Role of high-fat diet on letrozole-induced polycystic ovarian syndrome in rats","volume":"917","author":"Begum","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.steroids.2024.109558_b0070","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac097","article-title":"Distinctions in PCOS induced by letrozole vs dehydroepiandrosterone with high-fat diet in mouse model","volume":"163","author":"Poojary","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109558_b0075","article-title":"Mogroside V improves follicular development and ovulation in young-adult PCOS rats induced by letrozole and high-fat diet through promoting glycolysis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109558_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109424","article-title":"Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model","volume":"206","author":"He","year":"2024","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.steroids.2024.109558_b0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome\u2014a reappraisal","volume":"4","author":"Dunaif","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0090","article-title":"Insulin\u2010Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk","volume":"2016","author":"Lauretta","year":"2016","journal-title":"Int. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.steroids.2024.109558_b0095","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/clinem\/dgaa337","article-title":"Insulin sensitizers for improving the endocrine and metabolic profile in overweight women with PCOS","volume":"105","author":"Xing","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2024.109558_b0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1530\/eje.1.02156","article-title":"Insulin-sensitizing agents in polycystic ovary syndrome","volume":"154","author":"Pasquali","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0105","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1038\/s41598-018-27018-8","article-title":"Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus","volume":"8","author":"Hossain","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.steroids.2024.109558_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05826","article-title":"PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1\/SREBP-1c axis","volume":"6","author":"Singh","year":"2020","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.steroids.2024.109558_b0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5455\/medarh.2017.71.380-384","article-title":"Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model","volume":"71","author":"Murai","year":"2017","journal-title":"Med Arch"},{"issue":"5","key":"10.1016\/j.steroids.2024.109558_b0120","first-page":"4013","article-title":"Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study","volume":"17","author":"Tohma","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.steroids.2024.109558_b0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/molecules27020339","article-title":"Evaluation of the pharmacokinetics of the pancreastatin inhibitor PSTi8 peptide in rats: Integration of in vitro and in vivo findings","volume":"27","author":"Valicherla","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.steroids.2024.109558_b0130","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.fertnstert.2005.06.013","article-title":"Persistent estrus rat models of polycystic ovary disease: an update","volume":"84","author":"Singh","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2024.109558_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","author":"Xing","year":"2022","journal-title":"Int. J. Womens Health"},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s43088-022-00329-6","article-title":"Dysregulation of intraovarian redox status and steroidogenesis pathway in letrozole-induced PCOS rat model: a possible modulatory role of l-Carnitine","volume":"11","author":"Elmosalamy","year":"2022","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00580-023-03534-6","article-title":"Administration of metformin ameliorates endocrine abnormalities associated with mouse model of PCOS by increasing Cyp19a1 expression","volume":"33","author":"Shah","year":"2024","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.steroids.2024.109558_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1395331","article-title":"Roles of estrogen and its receptors in polycystic ovary syndrome","volume":"12","author":"Xu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.steroids.2024.109558_b0155","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2024.109558_b0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11596-015-1497-z","article-title":"High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway","volume":"35","author":"Liu","year":"2015","journal-title":"Journal of Huazhong University of Science and Technology [Medical Sciences]"},{"issue":"3","key":"10.1016\/j.steroids.2024.109558_b0165","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters","year":"2008","journal-title":"Biol. Reprod."},{"issue":"18","key":"10.1016\/j.steroids.2024.109558_b0170","doi-asserted-by":"crossref","first-page":"14126","DOI":"10.3390\/ijms241814126","article-title":"Polycystic ovary syndrome and oxidative stress\u2014from bench to bedside","volume":"24","author":"Zeber-Lubecka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2024.109558_b0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13813455.2018.1499120","article-title":"Insulin resistance and oxidative marker in women with PCOS","volume":"126","author":"Bannigida","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.steroids.2024.109558_b0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109558_b0185","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.steroids.2024.109558_b0190","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/diagnostics13091559","article-title":"Polycystic Ovary Syndrome: pathophysiology and controversies in diagnosis","volume":"13","author":"Fahs","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.steroids.2024.109558_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.741764","article-title":"Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109558_b0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12291-014-0447-z","article-title":"Correlations of insulin resistance and serum testosterone levels with LH: FSH ratio and oxidative stress in women with functional ovarian hyperandrogenism","volume":"30","author":"Suresh","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"issue":"10","key":"10.1016\/j.steroids.2024.109558_b0205","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrendo.2014.102","article-title":"The management of patients with polycystic ovary syndrome","volume":"10","author":"Jayasena","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2024.109558_b0210","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/jcm12041500","article-title":"Polycystic ovary syndrome: challenges and possible solutions","volume":"12","author":"Che","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.steroids.2024.109558_b0215","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.pec.2021.05.038","article-title":"The challenges with managing polycystic ovary syndrome: a qualitative study of women\u2019s and clinicians\u2019 experiences","volume":"105","author":"Copp","year":"2022","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.steroids.2024.109558_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.steroids.2024.109558_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170902","article-title":"Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice","volume":"159","author":"Goand","year":"2023","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.steroids.2024.109558_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05133","article-title":"Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice","volume":"6","author":"Singh","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.steroids.2024.109558_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170147","article-title":"Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT\/GSK-3\u03b2 and PKC\u03bb\/\u03b6\/SREBP1c pathways in high fat diet induced insulin resistance in peri-\/post-menopausal rats","volume":"120","author":"Valicherla","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.steroids.2024.109558_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108959","article-title":"Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL\/6 mice","volume":"116","author":"Gupta","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.steroids.2024.109558_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156354","article-title":"Immunometabolic impact of pancreastatin inhibitor PSTi8 in MCD induced mouse model of oxidative stress and steatohepatitis","volume":"171","author":"Goand","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.steroids.2024.109558_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175559","article-title":"Pancreastatin inhibitor PSTi8 ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production","volume":"944","author":"Garg","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.steroids.2024.109558_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120221","article-title":"Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: in vitro and in vivo findings","volume":"289","author":"Garg","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.steroids.2024.109558_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173204","article-title":"Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice","volume":"881","author":"Gupta","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109558_b0265","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/13880209.2015.1091482","article-title":"Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome","volume":"54","author":"Shah","year":"2016","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.repbio.2015.12.006","article-title":"Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome","volume":"16","author":"Cadagan","year":"2016","journal-title":"Reprod. Biol."},{"issue":"5","key":"10.1016\/j.steroids.2024.109558_b0275","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.steroids.2024.109558_b0280","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4161\/cc.5.11.2803","article-title":"Ovarian steroids: the good, the bad, and the signals that raise them","volume":"5","author":"Jamnongjit","year":"2006","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.steroids.2024.109558_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egyptian Journal of Medical Human Genetics"},{"issue":"4","key":"10.1016\/j.steroids.2024.109558_b0290","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2024.109558_b0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fendo.2018.00061","article-title":"Granulosa cell apoptosis in the ovarian follicle\u2014a changing view","volume":"9","author":"Regan","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109558_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.267","article-title":"The relationships of sex hormone\u2010binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome","volume":"4","author":"Simons","year":"2021","journal-title":"Endocrinology, Diabetes & Metabolism"},{"issue":"21","key":"10.1016\/j.steroids.2024.109558_b0305","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2024.109558_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172723","article-title":"Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK\/NOX3-JNK pathway","volume":"864","author":"Gupta","year":"2019","journal-title":"Eur. J. Pharmacol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2400196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2400196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T16:10:36Z","timestamp":1740327036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X2400196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":62,"alternative-id":["S0039128X2400196X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109558","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109558"}}